Orthopediatrics Corp Stock Analysis
KIDS Stock | USD 29.46 0.44 1.47% |
Orthopediatrics Corp is undervalued with Real Value of 36.13 and Target Price of 56.67. The main objective of Orthopediatrics Corp stock analysis is to determine its intrinsic value, which is an estimate of what Orthopediatrics Corp is worth, separate from its market price. There are two main types of Orthopediatrics Corp's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Orthopediatrics Corp's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Orthopediatrics Corp's stock to identify patterns and trends that may indicate its future price movements.
The Orthopediatrics Corp stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Orthopediatrics Corp is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Orthopediatrics Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Orthopediatrics Corp's ongoing operational relationships across important fundamental and technical indicators.
Orthopediatrics |
Orthopediatrics Stock Analysis Notes
About 32.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.96. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Orthopediatrics Corp recorded a loss per share of 0.92. The entity had not issued any dividends in recent years. OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana. OrthoPediatrics Corp operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 133 people. To find out more about Orthopediatrics Corp contact Mark Throdahl at 574 268 6379 or learn more at https://www.orthopediatrics.com.Orthopediatrics Corp Quarterly Total Revenue |
|
Orthopediatrics Corp Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Orthopediatrics Corp's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Orthopediatrics Corp or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Orthopediatrics Corp had very high historical volatility over the last 90 days | |
The company reported the previous year's revenue of 148.73 M. Net Loss for the year was (20.97 M) with profit before overhead, payroll, taxes, and interest of 90.66 M. | |
Orthopediatrics Corp currently holds about 51.16 M in cash with (27.05 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.52. | |
Orthopediatrics Corp has a poor financial position based on the latest SEC disclosures | |
Roughly 71.0% of the company shares are owned by institutional investors | |
Latest headline from hawaiinewsnow.com: School district implements lesson plan for elementary students about pronouns |
Orthopediatrics Corp Upcoming and Recent Events
Earnings reports are used by Orthopediatrics Corp to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Orthopediatrics Corp previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
27th of February 2024 Upcoming Quarterly Report | View | |
6th of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
27th of February 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Orthopediatrics Largest EPS Surprises
Earnings surprises can significantly impact Orthopediatrics Corp's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2023-11-06 | 2023-09-30 | -0.23 | -0.2 | 0.03 | 13 | ||
2019-05-08 | 2019-03-31 | -0.17 | -0.21 | -0.04 | 23 | ||
2018-10-31 | 2018-09-30 | -0.11 | -0.15 | -0.04 | 36 |
Orthopediatrics Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Orthopediatrics Corp is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Orthopediatrics Corp backward and forwards among themselves. Orthopediatrics Corp's institutional investor refers to the entity that pools money to purchase Orthopediatrics Corp's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Awm Investment Company Inc | 2023-12-31 | 425.6 K | State Street Corporation | 2023-12-31 | 420.1 K | Wasatch Advisors Inc. | 2023-12-31 | 413.7 K | Amvescap Plc. | 2023-12-31 | 408.3 K | Geode Capital Management, Llc | 2023-12-31 | 364.9 K | Wellington Management Company Llp | 2023-12-31 | 314.2 K | First Light Asset Management, Llc | 2023-12-31 | 297.5 K | Goldman Sachs Group Inc | 2023-12-31 | 195.8 K | Northern Trust Corp | 2023-12-31 | 185.1 K | Brown Capital Management, Llc | 2023-12-31 | 3.3 M | Brown Advisory Holdings Inc | 2023-12-31 | 1.6 M |
Orthopediatrics Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 700.74 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Orthopediatrics Corp's market, we take the total number of its shares issued and multiply it by Orthopediatrics Corp's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Orthopediatrics Profitablity
Orthopediatrics Corp's profitability indicators refer to fundamental financial ratios that showcase Orthopediatrics Corp's ability to generate income relative to its revenue or operating costs. If, let's say, Orthopediatrics Corp is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Orthopediatrics Corp's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Orthopediatrics Corp's profitability requires more research than a typical breakdown of Orthopediatrics Corp's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.14) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.21) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.21. Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.07) | (0.08) | |
Return On Capital Employed | (0.06) | (0.07) | |
Return On Assets | (0.05) | (0.05) | |
Return On Equity | (0.06) | (0.06) |
Management Efficiency
Orthopediatrics Corp has return on total asset (ROA) of (0.0372) % which means that it has lost $0.0372 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0555) %, meaning that it created substantial loss on money invested by shareholders. Orthopediatrics Corp's management efficiency ratios could be used to measure how well Orthopediatrics Corp manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.08 in 2024. Return On Capital Employed is likely to drop to -0.07 in 2024. At this time, Orthopediatrics Corp's Total Assets are comparatively stable compared to the past year. Net Tangible Assets is likely to gain to about 255.9 M in 2024, whereas Total Current Assets are likely to drop slightly above 122.2 M in 2024.Last Reported | Projected for Next Year | ||
Book Value Per Share | 16.63 | 17.46 | |
Net Current Asset Value | 0.00 | 0.00 | |
Tangible Asset Value | 0.00 | 0.00 | |
Tangible Book Value Per Share | 9.21 | 9.67 | |
Enterprise Value Over EBITDA | (86.85) | (91.20) | |
Price Book Value Ratio | 1.96 | 1.86 | |
Enterprise Value Multiple | (86.85) | (91.20) | |
Price Fair Value | 1.96 | 1.86 | |
Enterprise Value | 727.9 M | 379.5 M |
The analysis of Orthopediatrics Corp's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Orthopediatrics Corp's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Orthopediatrics Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta 1.181 |
Technical Drivers
As of the 19th of April, Orthopediatrics Corp holds the Semi Deviation of 2.58, risk adjusted performance of 0.0259, and Coefficient Of Variation of 3475.06. Orthopediatrics Corp technical analysis gives you tools to exploit past prices in attempt to determine a pattern that determines the direction of the company's future prices. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to break down nineteen technical drivers for Orthopediatrics Corp, which can be compared to its competitors. Please check Orthopediatrics Corp information ratio, potential upside, as well as the relationship between the Potential Upside and kurtosis to decide if Orthopediatrics Corp is priced some-what accurately, providing market reflects its current price of 29.46 per share. Given that Orthopediatrics Corp has jensen alpha of (0.06), we recommend you to check out Orthopediatrics Corp's recent market performance to make sure the company can sustain itself at a future point.Orthopediatrics Corp Price Movement Analysis
The output start index for this execution was eleven with a total number of output elements of fifty. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Orthopediatrics Corp middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Orthopediatrics Corp. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Orthopediatrics Corp Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Orthopediatrics Corp insiders, such as employees or executives, is commonly permitted as long as it does not rely on Orthopediatrics Corp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Orthopediatrics Corp insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Terry Schlotterback over six months ago Orthopediatrics Corp exotic insider transaction detected | ||
Terry Schlotterback over six months ago Sale by Terry Schlotterback of 2610 shares of Orthopediatrics Corp | ||
Terry Schlotterback over six months ago Exercise or conversion by Terry Schlotterback of 670 shares of Orthopediatrics Corp subject to Rule 16b-3 | ||
Terry Schlotterback over a year ago Orthopediatrics Corp exotic insider transaction detected | ||
Mark Throdahl over a year ago Acquisition by Mark Throdahl of 12266 shares of Orthopediatrics Corp subject to Rule 16b-3 | ||
Mark Throdahl over a year ago Sale by Mark Throdahl of 4515 shares of Orthopediatrics Corp |
Orthopediatrics Corp Predictive Daily Indicators
Orthopediatrics Corp intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Orthopediatrics Corp stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Accumulation Distribution | 3512.58 | |||
Daily Balance Of Power | (0.33) | |||
Rate Of Daily Change | 0.99 | |||
Day Median Price | 30.07 | |||
Day Typical Price | 29.86 | |||
Price Action Indicator | (0.82) | |||
Period Momentum Indicator | (0.44) | |||
Relative Strength Index | 46.7 |
Orthopediatrics Corp Corporate Filings
8th of April 2024 Other Reports | ViewVerify | |
15th of March 2024 Other Reports | ViewVerify | |
F4 | 12th of March 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 11th of March 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
10K | 8th of March 2024 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
8K | 6th of March 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 23rd of February 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 14th of February 2024 An amended filing to the original Schedule 13G | ViewVerify |
Orthopediatrics Corp Forecast Models
Orthopediatrics Corp's time-series forecasting models are one of many Orthopediatrics Corp's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Orthopediatrics Corp's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Orthopediatrics Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Orthopediatrics Corp prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Orthopediatrics shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Orthopediatrics Corp. By using and applying Orthopediatrics Stock analysis, traders can create a robust methodology for identifying Orthopediatrics entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | (0.14) | (0.15) | |
Operating Profit Margin | (0.17) | (0.18) | |
Net Loss | (0.14) | (0.15) | |
Gross Profit Margin | 0.63 | 0.80 |
Current Orthopediatrics Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Orthopediatrics analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Orthopediatrics analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
56.67 | Buy | 7 | Odds |
Most Orthopediatrics analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Orthopediatrics stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Orthopediatrics Corp, talking to its executives and customers, or listening to Orthopediatrics conference calls.
Orthopediatrics Stock Analysis Indicators
Orthopediatrics Corp stock analysis indicators help investors evaluate how Orthopediatrics Corp stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Orthopediatrics Corp shares will generate the highest return on investment. By understating and applying Orthopediatrics Corp stock analysis, traders can identify Orthopediatrics Corp position entry and exit signals to maximize returns.
Begin Period Cash Flow | 10.5 M | |
Total Stockholder Equity | 377 M | |
Total Liab | 72.6 M | |
Property Plant And Equipment Net | 41 M | |
Cash And Short Term Investments | 82.3 M | |
Net Invested Capital | 387.1 M | |
Cash | 33 M | |
50 Day M A | 28.0482 | |
Net Interest Income | -44 K | |
Total Current Liabilities | 41.7 M | |
Investments | 528 K | |
Interest Expense | -198 K | |
Stock Based Compensation | 10.5 M | |
Long Term Debt | 9.9 M | |
Common Stock Shares Outstanding | 22.7 M | |
Tax Provision | -174 K | |
Free Cash Flow | -46 M | |
Other Current Assets | 3.8 M | |
Accounts Payable | 12.6 M | |
Net Debt | -9.3 M | |
Depreciation | 17.4 M | |
Other Operating Expenses | 174.5 M | |
Non Current Assets Total | 223.1 M | |
Liabilities And Stockholders Equity | 449.6 M | |
Non Currrent Assets Other | 1.1 M |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Orthopediatrics Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. For more information on how to buy Orthopediatrics Stock please use our How to Invest in Orthopediatrics Corp guide.Note that the Orthopediatrics Corp information on this page should be used as a complementary analysis to other Orthopediatrics Corp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Complementary Tools for Orthopediatrics Stock analysis
When running Orthopediatrics Corp's price analysis, check to measure Orthopediatrics Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orthopediatrics Corp is operating at the current time. Most of Orthopediatrics Corp's value examination focuses on studying past and present price action to predict the probability of Orthopediatrics Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orthopediatrics Corp's price. Additionally, you may evaluate how the addition of Orthopediatrics Corp to your portfolios can decrease your overall portfolio volatility.
Global Correlations Find global opportunities by holding instruments from different markets | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |
Is Orthopediatrics Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Orthopediatrics Corp. If investors know Orthopediatrics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Orthopediatrics Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.92) | Revenue Per Share 6.559 | Quarterly Revenue Growth 0.214 | Return On Assets (0.04) | Return On Equity (0.06) |
The market value of Orthopediatrics Corp is measured differently than its book value, which is the value of Orthopediatrics that is recorded on the company's balance sheet. Investors also form their own opinion of Orthopediatrics Corp's value that differs from its market value or its book value, called intrinsic value, which is Orthopediatrics Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Orthopediatrics Corp's market value can be influenced by many factors that don't directly affect Orthopediatrics Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Orthopediatrics Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Orthopediatrics Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Orthopediatrics Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.